Non-small-cell lung cancer: how to manage BRAF-mutated disease

Giorgia Guaitoli, Lodovica Zullo, Marcello Tiseo, Matthew Dankner, April AN Rose, Francesco Facchinetti

Article Type

Review

Published

This review aims to offer a comprehensive update about available therapeutic options for patients with NSCLC harbouring BRAF mutations to guide the physician in the choice of treatment strategies.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.